Embracing Digital Shift: The ransomware attack on UnitedHealth Group's Change Healthcare unit last year underscored the urgent need for strong cybersecurity in healthcare. To enhance patient care ...

As healthcare startups hope for an opening in the IPO market this year, investors' standards for their public prospects are higher than ever. It's been a dismal few years for healthcare IPOs.

Counterpart is a subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”). This partnership will enable SIH’s care teams to excel in value-based care arrangements by ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

One of the most successful examples of this can be seen by looking at its former healthcare subsidiary, GE HealthCare Technologies (NASDAQ ... company can and will change as new data comes in.

Workforce challenges following the COVID-19 pandemic and the Change Healthcare breach, along with more industry interest in artificial intelligence and automated operations, are behind much of ...

Short interest in 1,672 securities on The Nasdaq Capital MarketSM totaled 2, Leading U.S. exchange by number of IPOs and proceeds raised for the sixth consecutive year Featured the largest IPO and ...

The WECLIMA group studies relationships between regionally impactful weather extremes and large-scale climate variability and change. We also collaborate across disciplines to study impacts on public ...

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when ...

As of Feb. 5, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum ...

Q4 2024 showed a significant miss in profitability despite a 4% YoY sales growth; gross profit margin dropped due to a one-time discount for a big new client. The FDA initiatives are interesting ...